Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

HSK-26784 shows efficacy in multiple B lymphocyte-derived malignancy models

June 30, 2020

Oblique Therapeutics and Targovax to combine platforms to target mutant RAS cancers

June 29, 2020

P53 'glue' gums up cancer cells

June 29, 2020

Cornell University patents IRE1 inhibitors

June 29, 2020

Discovery and preclinical characterization of novel dual inhibitor of LSD1-HDAC6, JBI-802

June 29, 2020

Sunshine Lake Pharma discovers RET inhibitors

June 29, 2020

New phase IIa study evaluates BO-112 with pembrolizumab for liver metastases

June 29, 2020

BGB-11417 demonstrates promising antitumor activities in hematological tumor models

June 26, 2020

Discovery of novel orally bioavailable brain-penetrant PRMT5 inhibitor, PRT-811

June 26, 2020

Precision model allows accurate cancer therapy testing

June 26, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Voyager’s gene therapy reduces tau levels in AD models
BioWorld Science
At the Alzheimer’s Association International Conference, researchers from Voyager Therapeutics Inc. presented preclinical efficacy data for VY-1706, a blood-brain...
GABA signaling linked to immune resistance in some tumors
BioWorld
Certain cancers that contain organized clusters of immune cells known as tertiary lymphoid structures (TLS) do not respond to treatment as well as expected. Even...